Category Canadian Bioethics
CASGEVY: Rethinking Drug Costs Through the Lens of Public Access
Maria Klimenko considers the extent to which the price of innovative treatments like CASGEVY, a type of gene therapy, should reflect not just the cost of development, but also their broader societal impact — and the public healthcare system’s ability to provide equitable access.
Climate, Health and Equity – Canada Must Lead with Action
Sharon E. Straus discusses the urgent need for the upcoming G7 summit to address climate change impacts on health.
Intellectual Disabilities and Autism: Ethics and Practice
Andria Bianchi and Janet A. Vogt introduce their new book which investigates ethical issues in the lives of people with intellectual and developmental disabilities and autistic people in health care and in other social contexts.




